OracleBio analysis data is presented at at American Society of Clinical Oncology (ASCO) in June 2022.
The poster, presented by Marie Cumberbatch from TriStar Technology Group, is collaborative work between TriStar, Ultivue, and OracleBio.
The work involved multiplex IF staining and analysis of multi-tumor tissue microarrays, with this poster focusing on the contribution of macrophages to the overall tumor PD-L1 microenvironment across different cancer types.
Such target prevalence data can help guide options for successful immunotherapy strategies.
Click the thumbnail image below to view or download the high-resolution poster PDF:
More from OracleBio:
Utilizing Quantitative Digital Pathology techniques for analysis of Hepatitis B liver samples stained with a 12-plex multiplex-IF assay
OracleBio data is presented at the 8th Digital Pathology & AI Congress: USA 2022 in New York. The poster, produced in collaboration with Gilead, involved a comprehensive evaluation of Hepatitis B liver samples stained using a 12-plex assay, with this poster...
A Quantitative Digital Pathology Workflow to Manage Technical Challenges within Multiplex IF R&D Studies
This poster, created in collaboration with Bristol Myers Squibb, details OracleBio's robust image analysis workflow in Indica Labs HALO, and how it helped overcome common technical issues encountered in a large multiplex IF (mIF) non-small cell lung cancer (NSCLC)...
Comparative multiplex digital phenotyping of the tumour microenvironment across multiple tumour types using a well characterized multi-tumour tissue microarray
OracleBio 8-plex TMA analysis data is presented at the AACR Virtual Annual Meeting in April 2021 and the Digital Pathology & AI Congress: Europe in December 2021. The poster, produced in collaboration with Ultivue and TriStar Technology Group, focuses on the...
Learn More About OracleBio's Multiplex IF Analysis
Explore OracleBio's Scientific Posters
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more